ITIM
NVO

Indiana Trust & Investment Management’s Novo Nordisk NVO Stock Holding History

Indiana Trust & Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Hold
491
– – 0.01% 353
2026
Q1 		$18K Hold
491
– – 0.01% 368
2025
Q4 		$25K Hold
491
– – 0.01% 332
2025
Q3 		$27.2K Hold
491
– – 0.01% 326
2025
Q2 		$33.9K Hold
491
– – 0.01% 313
2025
Q1 		$34.1K Hold
491
– – 0.01% 315
2024
Q4 		$42.2K Hold
491
– – 0.01% 303
2024
Q3 		$58.5K Hold
491
– – 0.02% 282
2024
Q2 		$70.1K Buy
+491
New +$65.1K 0.03% 253

Other funds holding NVO

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Indiana Trust & Investment Management's NVO Position: Q2 2026 in Review

Indiana Trust & Investment Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 491 shares worth $23.5K. The position accounts for 0.01% of the portfolio, ranked #353.

Indiana Trust & Investment Management first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $70.1K in Q2 2024. 635 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Indiana Trust & Investment Management held 491 shares of Novo Nordisk worth $23.5K as of Q2 2026.
  • Indiana Trust & Investment Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #353 holding.
  • Indiana Trust & Investment Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Indiana Trust & Investment Management's Novo Nordisk position peaked at $70.1K in Q2 2024.
  • 635 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.